102 related articles for article (PubMed ID: 27509643)
1. Rapidly Fatal Dissemination of Merkel Cell Carcinoma in a Patient Treated with Alemtuzumab for Chronic Lymphocytic Leukemia.
Yu KK; Dasanu CA
Conn Med; 2016; 80(6):353-8. PubMed ID: 27509643
[TBL] [Abstract][Full Text] [Related]
2. Second malignancies in chronic lymphocytic leukemia.
Streu E
Oncol Nurs Forum; 2014 Jan; 41(1):95-8. PubMed ID: 24368244
[No Abstract] [Full Text] [Related]
3. Fludarabine plus alemtuzumab versus fludarabine alone in patients with previously treated chronic lymphocytic leukaemia: a randomised phase 3 trial.
Elter T; Gercheva-Kyuchukova L; Pylylpenko H; Robak T; Jaksic B; Rekhtman G; Kyrcz-Krzemień S; Vatutin M; Wu J; Sirard C; Hallek M; Engert A
Lancet Oncol; 2011 Dec; 12(13):1204-13. PubMed ID: 21992852
[TBL] [Abstract][Full Text] [Related]
4. Fludarabine plus alemtuzumab (FA) front-line treatment in young patients with chronic lymphocytic leukemia (CLL) and an adverse biologic profile.
Mauro FR; Molica S; Laurenti L; Cortelezzi A; Carella AM; Zaja F; Chiarenza A; Angrilli F; Nobile F; Marasca R; Musolino C; Brugiatelli M; Piciocchi A; Vignetti M; Fazi P; Gentile G; De Propris MS; Della Starza I; Marinelli M; Chiaretti S; Del Giudice I; Nanni M; Albano F; Cuneo A; Guarini A; Foà R;
Leuk Res; 2014 Feb; 38(2):198-203. PubMed ID: 24314589
[TBL] [Abstract][Full Text] [Related]
5. Bendamustine plus alemtuzumab is safe and feasible treatment for fludarabine refractory chronic lymphocytic leukaemia (CLL).
Hill BT; Caimi P; Kindwall-Keller T; Habecker B; Kalaycio M
Br J Haematol; 2014 Jan; 164(2):297-9. PubMed ID: 24131326
[No Abstract] [Full Text] [Related]
6. Intense reversal of bone marrow angiogenesis after sequential fludarabine-induction and alemtuzumab-consolidation therapy in advanced chronic lymphocytic leukemia.
Molica S; Montillo M; Ribatti D; Mirabelli R; Tedeschi A; Ricci F; Veronese S; Vacca A; Morra E
Haematologica; 2007 Oct; 92(10):1367-74. PubMed ID: 17768114
[TBL] [Abstract][Full Text] [Related]
7. Fatal adenovirus infection during alemtuzumab (anti-CD52 monoclonal antibody) treatment of a patient with fludarabine-refractory B-cell chronic lymphocytic leukemia.
Cavalli-Björkman N; Osby E; Lundin J; Kalin M; Osterborg A; Gruber A
Med Oncol; 2002; 19(4):277-80. PubMed ID: 12512923
[TBL] [Abstract][Full Text] [Related]
8. Accelerated growth of skin carcinoma following fludarabine therapy for chronic lymphocytic leukemia.
Rashid K; Ng R; Mastan A; Sager D; Hirschman R
Leuk Lymphoma; 2005 Jul; 46(7):1051-5. PubMed ID: 16019557
[TBL] [Abstract][Full Text] [Related]
9. Combination therapy with fludarabine and rituximab followed by alemtuzumab in the first-line treatment of patients with chronic lymphocytic leukemia or small lymphocytic lymphoma: a phase 2 trial of the Minnie Pearl Cancer Research Network.
Hainsworth JD; Vazquez ER; Spigel DR; Raefsky E; Bearden JD; Saez RA; Greco FA
Cancer; 2008 Mar; 112(6):1288-95. PubMed ID: 18189296
[TBL] [Abstract][Full Text] [Related]
10. Advances in the diagnosis and treatment of chronic lymphocytic leukemia.
Abbott BL
Clin Adv Hematol Oncol; 2004 Jul; 2(7):448-54. PubMed ID: 16163221
[TBL] [Abstract][Full Text] [Related]
11. Plasma alemtuzumab levels in patients with chronic lymphocytic leukemia treated with alemtuzumab combined with chemotherapy reflect the efficacy of the treatment: a hypothesis.
Vojdeman FJ; Jurlander J; van't Veer M; Itälä-Remes M; Kimby E; Tjønnfjord GE; Walewski J; Kozák T; Polliack A; Montagna M; Regazzi M; Kirkby N; van Oers M; Geisler CH
Leuk Lymphoma; 2013 Apr; 54(4):790-3. PubMed ID: 23025267
[TBL] [Abstract][Full Text] [Related]
12. Merkel cell carcinoma with partial B-cell blastic immunophenotype: a potential mimic of cutaneous richter transformation in a patient with chronic lymphocytic lymphoma.
Papalas JA; McKinney MS; Kulbacki E; Dave SS; Wang E
Am J Dermatopathol; 2014 Feb; 36(2):148-52. PubMed ID: 24556900
[TBL] [Abstract][Full Text] [Related]
13. Subcutaneous alemtuzumab in fludarabine-refractory chronic lymphocytic leukemia: clinical results and prognostic marker analyses from the CLL2H study of the German Chronic Lymphocytic Leukemia Study Group.
Stilgenbauer S; Zenz T; Winkler D; Bühler A; Schlenk RF; Groner S; Busch R; Hensel M; Dührsen U; Finke J; Dreger P; Jäger U; Lengfelder E; Hohloch K; Söling U; Schlag R; Kneba M; Hallek M; Döhner H;
J Clin Oncol; 2009 Aug; 27(24):3994-4001. PubMed ID: 19597025
[TBL] [Abstract][Full Text] [Related]
14. [Merkel cell carcinoma in a patient with chronic lymphocytic leukemia].
Cervigón I; Gargallo AB; Bahillo C; Martínez-Amo JL; Orradre JL; Muñoz-Madero V; García-Almagro D
Actas Dermosifiliogr; 2006 May; 97(4):264-6. PubMed ID: 16801021
[TBL] [Abstract][Full Text] [Related]
15. Alemtuzumab as consolidation after a response to fludarabine is effective in purging residual disease in patients with chronic lymphocytic leukemia.
Montillo M; Tedeschi A; Miqueleiz S; Veronese S; Cairoli R; Intropido L; Ricci F; Colosimo A; Scarpati B; Montagna M; Nichelatti M; Regazzi M; Morra E
J Clin Oncol; 2006 May; 24(15):2337-42. PubMed ID: 16618945
[TBL] [Abstract][Full Text] [Related]
16. Fludarabine in combination with alemtuzumab is effective and feasible in patients with relapsed or refractory B-cell chronic lymphocytic leukemia: results of a phase II trial.
Elter T; Borchmann P; Schulz H; Reiser M; Trelle S; Schnell R; Jensen M; Staib P; Schinköthe T; Stützer H; Rech J; Gramatzki M; Aulitzky W; Hasan I; Josting A; Hallek M; Engert A
J Clin Oncol; 2005 Oct; 23(28):7024-31. PubMed ID: 16145065
[TBL] [Abstract][Full Text] [Related]
17. Flare-up of squamous cell carcinoma of the skin following fludarabine therapy for chronic lymphocytic leukemia.
Davidovitz Y; Ballin A; Meytes D
Acta Haematol; 1997; 98(1):44-6. PubMed ID: 9210914
[TBL] [Abstract][Full Text] [Related]
18. Prostatic and renal aspergillosis due to Aspergillus fumigatus in a patient receiving alemtuzumab for chronic lymphocytic leukaemia.
Roux C; Thyss A; Gari-Toussaint M
J Mycol Med; 2013 Dec; 23(4):270-3. PubMed ID: 24210582
[TBL] [Abstract][Full Text] [Related]
19. Merkel cell carcinoma after chronic lymphocytic leukemia: case report and literature review.
Vlad R; Woodlock TJ
Am J Clin Oncol; 2003 Dec; 26(6):531-4. PubMed ID: 14663367
[TBL] [Abstract][Full Text] [Related]
20. Fludarabine and mitoxantrone for patients with chronic lymphocytic leukemia.
Tsimberidou AM; Keating MJ; Giles FJ; Wierda WG; Ferrajoli A; Lerner S; Beran M; Andreeff M; Kantarjian HM; O'Brien S
Cancer; 2004 Jun; 100(12):2583-91. PubMed ID: 15197800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
